Esperion Therapeutics | DEF 14A:股东委托书决议
04/11 16:26 (美东)
Esperion Therapeutics | ARS:年度报告
04/11 16:21 (美东)
Esperion Therapeutics | 4:持股变动声明-高管 Koenig Sheldon L.
03/15 22:17 (美东)
Esperion Therapeutics | 4:持股变动声明-高管 Warren Eric
03/15 22:17 (美东)
Esperion Therapeutics | 4:持股变动声明-高管 Foody Joanne M.
03/15 16:42 (美东)
Esperion Therapeutics | 4:持股变动声明-高管 Halladay Benjamin
03/15 16:37 (美东)
Esperion Therapeutics | 4:持股变动声明-高管 Looker Benjamin
03/15 16:37 (美东)
Esperion Therapeutics | 10-K:年度报表
02/27 09:21 (美东)
Esperion Therapeutics | 8-K:Esperion公布2023年第四季度和全年财务业绩
02/27 07:25 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-CVI Investments, Inc.(0%),Heights Capital Management, Inc.(0%)
02/14 14:19 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Two Seas Capital LP(6.8%),Two Seas Capital GP LLC(6.8%)等
02/14 10:52 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%)等
02/14 08:46 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Cubist Systematic Strategies, LLC(0.2%),Steven A. Cohen(0.2%)等
02/14 06:16 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(4.52%)
02/13 22:53 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
02/09 16:33 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BB Biotech AG(5.1%),Biotech Target N.V. N/A(5.1%)
01/24 15:50 (美东)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BB Biotech AG(3.7%),Biotech Target N.V. N/A(3.7%)
01/24 15:25 (美东)
Esperion Therapeutics | 8-K:重大事件
01/22 00:00 (美东)
Esperion Therapeutics | 424B5:募资说明书
01/22 00:00 (美东)
Esperion Therapeutics | 8-K:重大事件
01/18 00:00 (美东)
暂无数据
暂无数据